Woodline Partners’s Outset Medical OM Stock Holding History
Bought
Maintained
Sold
Other funds holding OM
BCM
PA
PHS
Woodline Partners's OM Position: Q2 2026 in Review
Woodline Partners sold out of Outset Medical (OM) in Q2 2026, closing a stake of 292,437 shares — an estimated $1.12M sold.
Woodline Partners first reported a position in OM in Q3 2020 and held it in 15 quarters. The position peaked at $25.5M in Q2 2025. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.
- Woodline Partners reported no remaining Outset Medical position as of Q2 2026 after selling out during the quarter.
- Woodline Partners sold 292,437 Outset Medical shares in Q2 2026, an estimated $1.12M.
- Woodline Partners first reported a position in Outset Medical in Q3 2020 and held it in 15 quarters.
- Woodline Partners's Outset Medical position peaked at $25.5M in Q2 2025.
- 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.
Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.